Altimmune Inc’s filing revealed that its Chief Financial Officer WEAVER GREGORY L acquired Company’s shares for reported $51996.0 on Mar 13 ’25. In the deal valued at $5.20 per share,10,000 shares were bought. As a result of this transaction, WEAVER GREGORY L now holds 10,000 shares worth roughly $59200.0.
Then, Drutz David sold 16,011 shares, generating $110,547 in total proceeds. Upon selling the shares at $6.90, the Director now owns 41,958 shares.
William Blair initiated its Altimmune Inc [ALT] rating to a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. UBS began covering ALT with “Buy” recommendation on November 12, 2024. Guggenheim revised its rating on April 29, 2024. It rated ALT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ALT
On Friday, Altimmune Inc [NASDAQ:ALT] saw its stock jump 13.85% to $5.92. Over the last five days, the stock has gained 6.28%. Altimmune Inc shares have fallen nearly -17.89% since the year began. Nevertheless, the stocks have fallen -45.54% over the past one year. While a 52-week high of $11.16 was reached on 01/08/25, a 52-week low of $5.14 was recorded on 03/13/25. SMA at 50 days reached $6.50, while 200 days put it at $6.97.
Levels Of Support And Resistance For ALT Stock
The 24-hour chart illustrates a support level at 5.50, which if violated will result in even more drops to 5.08. On the upside, there is a resistance level at 6.20. A further resistance level may holdings at 6.47. The Relative Strength Index (RSI) on the 14-day chart is 47.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 52.44%. Stochastics %K at 25.25% indicates the stock is a holding.
How much short interest is there in Altimmune Inc?
A steep rise in short interest was recorded in Altimmune Inc stocks on 2025-02-28, dropping by -1.65 million shares to a total of 21.67 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 23.32 million shares. There was a decline of -7.64%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 24, 2024 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $13 price target.
